Encompass Health Receivables 2010-2024 | EHC

Encompass Health receivables for the quarter ending June 30, 2024 were $0.590B, a 10.78% increase year-over-year.

  • Encompass Health receivables for 2023 were $0.612B, a 13.93% increase from 2022.
  • Encompass Health receivables for 2022 were $0.537B, a 4.07% increase from 2021.
  • Encompass Health receivables for 2021 were $0.516B, a 9.95% decline from 2020.

Encompass Health Receivables 2010-2024 | EHC

  • Encompass Health receivables for 2023 were $0.612B, a 13.93% increase from 2022.
  • Encompass Health receivables for 2022 were $0.537B, a 4.07% increase from 2021.
  • Encompass Health receivables for 2021 were $0.516B, a 9.95% decline from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$17.3B
DaVita (DVA)$13.7B
Chemed (CHE)$8.7B
Elanco Animal Health (ELAN)$7.2B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$5B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.8B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1B
Atai Life Sciences (ATAI)$208M
Daxor (DXR)$45M
ATI Physical Therapy (ATIP)$25M
MEDIROM Healthcare Technologies (MRM)$19M
Psychemedics (PMD)$14M
Ontrak (OTRK)$10M
Novo Integrated Sciences (NVOS)$6M
IMAC Holdings (BACK)$2M